QuadraMed appoints James as CEO

Health IT systems developer QuadraMed has appointed Duncan W. James as its CEO and a member of the board of directors.

James, a former McKesson executive for the past nine years, will be responsible for the strategic and operational leadership of QuadraMed's global sales, marketing, product management, product development and customer service, according to the Reston, Va.-based company.

James joined QuadraMed Monday as executive vice president and will assume the office of CEO uponthe company's filing of its second quarter 2009 quarterly report on Form 10-Q, which it expects to file in the first week of August 2009. At that point, he will succeed James E. Peebles, who has served as QuadraMed's interim president and CEO since March.

Previously, James was the group president for the health systems solutions business at McKesson Provider Technologies.  In this role, he was responsible for the strategy and day-to-day operations of McKesson's portfolio of clinical, revenue cycle, decision support and enterprise imaging solutions for the hospital and health system market. In addition, QuadraMed said he has held multiple executive roles in operations, sales, and marketing at iXL Enterprises and Digital Equipment. 

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup